Summary
Definição
História e exame físico
Principais fatores diagnósticos
- dyspnea
- cough
- wheeze
- changes in sputum volume/color/thickness
- tachypnea
- cyanosis
Outros fatores diagnósticos
- past medical history of COPD
- tobacco dependence
- past medical history of gastroesophageal reflux/swallowing dysfunction
- malaise and fatigue
- chest tightness
- features of cor pulmonale
- environmental/occupational exposure to pollutants or dust
- change in mental status
- fever
- accessory muscle use
- paradoxical movements of abdomen
Fatores de risco
- viral infection
- bacterial infection
- gastroesophageal reflux/swallowing dysfunction
- smoking
- atypical bacterial infection
- air pollutants
- change in weather
Investigações diagnósticas
Primeiras investigações a serem solicitadas
- oxygen saturation on pulse oximetry
- chest x-ray
- ECG
- ABG
- CBC with differential
- eosinophil count
- CRP
- basic metabolic panel for electrolytes, BUN, + creatinine
Investigações a serem consideradas
- sputum culture + Gram stain
- respiratory virus diagnostics
- cardiac troponin
- B-type natriuretic peptide (BNP)
- CT scan of chest
Algoritmo de tratamento
Colaboradores
Consultores especialistas
Carolyn L. Rochester, MD
Professor of Medicine
Yale School of Medicine
New Haven
VA Connecticut Healthcare System
West Haven
CT
Declarações
CLR serves on the COPD scientific advisory board for GlaxoSmithKline Pharmaceuticals but has no competing interests pertaining to this publication.
Richard A. Martinello, MD
Associate Professor
Yale School of Medicine
New Haven
CT
Declarações
RAM declares that he has no competing interests.
Revisores
Antonio Anzueto, MD
Professor of Medicine
University of Texas Health
Section Chief
South Texas Veterans Health Care System
San Antonio
TX
利益声明
AA has been a consultant for GlaxoSmithKline, AstraZeneca, Boehringer-Ingelheim, Theravance and Grifols. AA has been reimbursed for his services by these companies. AA is a member of the GOLD scientific committee.
Peer reviewer acknowledgements
BMJ Best Practice topics are updated on a rolling basis in line with developments in evidence and guidance. The peer reviewers listed here have reviewed the content at least once during the history of the topic.
Disclosures
Peer reviewer affiliations and disclosures pertain to the time of the review.
参考文献
关键文献
Global Initiative for Chronic Obstructive Lung Disease. Global strategy for prevention, diagnosis and management of COPD: 2025 report. 2025 [internet publication].全文
Stevermer JJ, Fisher L, Lin KW, et al. Pharmacologic management of COPD exacerbations: a clinical practice guideline from the AAFP. Am Fam Physician. 2021 Jul 1;104(1):Online.全文 摘要
Spruit MA, Singh SJ, Garvey C, et al. An official American Thoracic Society/European Respiratory Society statement: key concepts and advances in pulmonary rehabilitation. Am J Respir Crit Care Med. 2013 Oct 15;188(8):e13-64. 摘要
参考文献
A full list of sources referenced in this topic is available here.
内容使用需遵循免责声明